Indian Immunologicals Limited Syringe Export Data — India (DGFT 2022–2026)

Name: Indian Immunologicals Limited Syringe Export Records India — #3 Exporter, 158 Shipments, $7.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Syringe

India Pharmaceutical Trade Intelligence

$179.9M291 Suppliers154 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → BELGIUM14.1%

#1 Buyer: FRESENIUS KABI

Indian Immunologicals Limited — Syringe Exporter #3 | $8.3M Trade Value | TransData Nexus | TransData Nexus

Indian Immunologicals Limited — Syringe Exporter Profile

Indian Pharmaceutical Exporter · #3 for Syringe · $8.3M export value · DGFT Verified

Indian Immunologicals Limited is the #3 Indian exporter of Syringe with $8.3M in export value and 158 verified shipments. Indian Immunologicals Limited holds a 4.4% market share in Syringe exports across 20 countries. The company exports 3 pharmaceutical products worth $29.1M across 3 therapeutic categories.

Indian Immunologicals Limited — Syringe Export Profile: Buyers & Destinations

Indian Immunologicals Limited Syringe export treemap — buyers and destination countries | TransData Nexus

Where Does Indian Immunologicals Limited Export Syringe?

Country	Value	Shipments	Share
TURKEY	$1.9M	39	26.0%
PHILIPPINES	$1.3M	25	16.6%
VIETNAM, DEMOCRATIC REP. OF	$850.0K	17	11.3%
VIETNAM	$700.0K	14	9.3%

Who Are the Top Buyers of Syringe from Indian Immunologicals Limited?

Buyer	Country	Value	Orders
CENTURION ILAC SANAYI VE TICARET AN	TURKEY	$1.7M	34
2 WORLD TRADERS INC	PHILIPPINES	$1.2M	24
DUC MINH MEDICAL JOINT STOCK COMPAN	VIETNAM	$1.0M	20
DUC MINH MEDIACL JOINT STOCK COMPAN	VIETNAM, DEMOCRATIC REP. OF	$350.0K	7
NEPAL INVESTMENT MEGA BANK LTD.	NEPAL	$296.2K	6
NEW AVAKASH INTERNATIONAL	ZIMBABWE	$293.6K	7
HYGIEIA BIOGENICS MYANMAR COMPANY L	MYANMAR	$250.0K	5
I AND M BANK LTD	KENYA	$250.0K	5
CENTURION ILAC SANAYI VE TICARET	TURKEY	$200.0K	4
DUC MINH MEDICAL JOINT STOCK	VIETNAM	$200.0K	4

Indian Immunologicals Limited supplies Syringe to 43 buyers globally. The largest buyer is CENTURION ILAC SANAYI VE TICARET AN (TURKEY), followed by 2 WORLD TRADERS INC (PHILIPPINES) and DUC MINH MEDICAL JOINT STOCK COMPAN (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Syringe Formulations Does Indian Immunologicals Limited Export?

Product Description / Formulation	Value	Shipments
ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT)	$1.5M	30
ABHAYRAB 0.5ML(HUMAN RABIES VACCINE WITHDILUENT AND SYRINGE)	$450.0K	9
ABHAYRAB 0.5ML BP(HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT)	$449.7K	9
ABHAYRAB 0 5ML BP HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT	$174.8K	4
ABHAYRAB 0.5ML B.PHUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT	$172.4K	4
ABHAYRAB 0 5ML HUMAN RABIES VACCINE WITHDILUENT AND SYRINGE	$150.0K	3
ABHAYRAB 0.5ML(HUMAN RABIES VACCINE WITHDILUENT AND SYRINGE)NOS	$150.0K	3
ABHAYRAB 0.5 ML (HUMAN RABIES VACCINE WITH DILUENT SYRINGE) BATCH NO:23URAB077MFG DT:SEP, 2023 EXP DT:AUG,2026NOS	$150.0K	3
ABHAYRAB 0.5 ML B.P ( WITH DISPOSABLE SYRINGE AND DILUENT)VLS	$150.0K	3
ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT) BATCH NO:23URAB055, BATCH NO:23URAB076, BAT	$150.0K	3

Indian Immunologicals Limited exports 85 distinct Syringe formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRIN with 30 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Indian Immunologicals Limited Compare to Nearest Syringe Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GLAND PHARMA LTD	$30.9M	619	22	$50.0K
2	GLAND PHARMA LIMITED	$11.7M	234	19	$50.0K
3	INDIAN IMMUNOLOGICALS LIMITED ★	$7.9M	158	20	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$5.0M	99	6	$50.0K
8	BRAWN LABORATORIES LIMITED	$3.1M	62	5	$50.0K

Indian Immunologicals Limited ranks #3 among 291 Indian Syringe exporters. Average shipment value of $50.0K compared to the market average of $231.1K. The closest competitors by value are GLAND PHARMA LTD and GLAND PHARMA LIMITED.

Which Indian Ports Ship Syringe Exports?

Port	Shipments	% Share
HYDERABAD ICD	447	12.7%
SAHAR AIR CARGO ACC (INBOM4)	290	8.2%
SAHAR AIR	282	8.0%
AHEMDABAD AIR	219	6.2%
AHEMDABAD AIR ACC (INAMD4)	209	5.9%
DELHI AIR	187	5.3%
NHAVA SHEVA SEA (INNSA1)	138	3.9%
HYDERABAD ICD (INSNF6)	127	3.6%

Geopolitical & Trade Policy Impact on Indian Immunologicals Limited's Syringe Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like IIL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels via the Cape of Good Hope. This has resulted in elongated lead times and increased shipping costs, disproportionately affecting time-sensitive pharmaceutical shipments. (pharmaceuticalcommerce.com) Additionally, the Middle East crisis has led to potential losses ranging between ₹2,500 crore and ₹5,000 crore for the Indian pharmaceutical industry due to supply chain disruptions. (outlookbusiness.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of new tariffs by the US administration, with rates reaching as high as 39% on imports from countries including India, poses a significant challenge. (apnews.com) These tariffs could impact nearly 55% of India's exports to the US, affecting long-standing client relationships and profit margins.

In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must invest in serialization and traceability systems to meet these stringent requirements, ensuring continued access to the lucrative EU market.

Indian Immunologicals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA and WHO intensifying inspections to ensure compliance with Good Manufacturing Practices (GMP). In 2023, the US FDA conducted over 200 inspections in India, with plans to increase this number in 2024, reflecting a growing emphasis on quality assurance. (fact.net.in) For IIL, maintaining rigorous quality standards is paramount, especially in light of incidents like the circulation of counterfeit batches of its rabies vaccine, Abhayrab®, in India since 2023. (health.gov.au) Such events underscore the necessity for robust quality control measures to safeguard product integrity and public trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Syringe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Indian Immunologicals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 166 individual customs records matching Indian Immunologicals Limited exporting Syringe, covering 85 formulations to 26 countries via 43 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 154+ countries, 751+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Syringe

Syringe

Indian Immunologicals Limited — Syringe Exporter Profile

Indian Immunologicals Limited — Syringe Export Profile: Buyers & Destinations

Where Does Indian Immunologicals Limited Export Syringe?

Who Are the Top Buyers of Syringe from Indian Immunologicals Limited?

What Is India's Total Syringe Export Value and How Much Does Indian Immunologicals Limited Contribute?

What Is the Average Shipment Value for Indian Immunologicals Limited's Syringe Exports?

How Does Indian Immunologicals Limited Compare to Other Indian Syringe Exporters?

What Syringe Formulations Does Indian Immunologicals Limited Export?

How Does Indian Immunologicals Limited Compare to Nearest Syringe Exporters?

Which Indian Ports Ship Syringe Exports?

Geopolitical & Trade Policy Impact on Indian Immunologicals Limited's Syringe Exports

Indian Immunologicals Limited — Regulatory Compliance & Quality Standards

About Indian Immunologicals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Syringe Export Data from Indian Immunologicals Limited

Syringe Stats

Company Overview

Top Products by Indian Immunologicals Limited

Related Analysis

Need Detailed Export Data?

Data Source